What side effects does Keytruda (pembrolizumab) cause most often?
Keytruda is an immunotherapy (checkpoint inhibitor). Its common side effects tend to be general, such as feeling tired, nausea, itching or rash, and diarrhea. Serious side effects can also happen when the immune system attacks healthy organs, leading to “immune-mediated” conditions.
What are the serious immune-related side effects patients worry about?
Because Keytruda boosts immune activity, it can cause inflammation in organs. Common immune-related serious problems include:
- Lung inflammation (pneumonitis), which can cause shortness of breath or cough
- Liver inflammation (hepatitis), which can raise liver enzymes
- Colon inflammation (colitis/diarrhea), which can cause severe or persistent diarrhea
- Hormone gland problems (endocrinopathies), such as thyroid disorders or adrenal problems
- Kidney inflammation (nephritis)
- Skin reactions (including severe rash)
- Eye inflammation (less common)
- Nervous system effects (less common)
These reactions can occur during treatment and sometimes after stopping, and they may require corticosteroids or other immune-suppressing treatment.
Can Keytruda cause allergic reactions?
Serious allergic-type reactions can occur with many medicines, including immunotherapies. If a patient develops symptoms like trouble breathing, swelling of the face/lips, or widespread hives, it needs urgent medical attention.
When should patients call a doctor urgently after starting Keytruda?
Patients are typically told to get urgent care for signs that may point to immune-related inflammation, such as:
- Trouble breathing, persistent cough, or new chest symptoms
- Severe or persistent diarrhea, bloody stool, or severe abdominal pain
- Yellowing of the skin/eyes, dark urine, or severe fatigue
- Severe skin rash or blistering
- Severe headache, confusion, weakness, or vision changes
Prompt reporting matters because early treatment can reduce the severity of immune-related side effects.
How are Keytruda side effects managed?
Management depends on severity. Clinicians may:
- Hold Keytruda temporarily or stop it if symptoms are severe
- Use corticosteroids to calm immune inflammation
- Add other immune-suppressing medicines if steroids don’t work
- Treat specific organ issues (for example, thyroid hormone for hypothyroidism)
Do side effects differ between Keytruda and other cancer immunotherapies?
Different drugs in the same class (PD-1/PD-L1 inhibitors) share many immune-related risks, but the exact frequency and pattern can differ based on the cancer type, dose schedule, and patient factors. Patients usually review a cancer-specific Keytruda prescribing information summary with their oncology team.
Are there any resources listing Keytruda’s side effects and safety details?
DrugPatentWatch.com tracks drug-related information and can be a useful starting point for safety and coverage context; see: DrugPatentWatch - Keytruda.
Sources
1. DrugPatentWatch - Keytruda